Christine M. DeBiase, EVP, CLO and General Counsel of Allstate Corp, filed a Form 4 on November 10, 2026, reporting option exercises and open-market sales of common stock totaling 28,652 shares on November 6, 2026.

Key Highlights

  • First option exercise: DeBiase exercised 21,368 employee stock options at an exercise price of $137.10, acquiring 21,368 shares of common stock.
  • Second option exercise: DeBiase exercised 7,284 employee stock options at an exercise price of $159.17, acquiring 7,284 shares of common stock.
  • Open-market sales: All 21,368 shares from the first exercise were sold at a weighted average price of $261.907, and all 7,284 shares from the second exercise were sold at a weighted average price of $261.4201.
  • Sale price range: Actual sale prices for the open-market transactions ranged from $261.760 to $262.210, according to the filing.
  • Remaining beneficial ownership: Following all reported transactions, DeBiase directly held 12,066.904 shares of common stock and 3,642 derivative securities.
  • Remaining option increment: The filing notes that 3,642 options from a February 21, 2024 award of 10,926 shares remain, with the final increment vesting on February 21, 2027.

DeBiase Option Exercises and Stock Sales on November 6, 2026

According to the Form 4 filed with the SEC, Christine M. DeBiase, serving as Executive Vice President, Chief Legal Officer, and General Counsel of Allstate Corp (NYSE:ALL), reported two separate option exercise-and-sale sequences on November 6, 2026. In the first transaction, she exercised 21,368 employee stock options carrying an exercise price of $137.10 per share, bringing her directly held shares to 33,434.904. She then sold all 21,368 acquired shares on the open market at a weighted average price of $261.907, reducing her direct holdings to 12,066.904 shares.

In the second sequence, DeBiase exercised 7,284 employee stock options at an exercise price of $159.17 per share, temporarily increasing her direct holdings to 19,350.904 shares, before selling all 7,284 shares at a weighted average price of $261.4201. Her direct common stock holdings returned to 12,066.904 shares following this sale. The filing states that actual sale prices for the open-market transactions ranged from $261.760 to $262.210, and that full information on shares sold at each separate price is available upon request.

Regarding the derivative securities, the filing explains that the 7,284 options exercised were part of a stock option award granted on February 21, 2024 for 10,926 shares of common stock, vesting in three equal increments. Following the exercise, 3,642 options remain, with the last increment scheduled to vest on February 21, 2027. The first option tranche exercised, covering 21,368 shares, had a date exercisable of February 16, 2026, and an expiration date of February 16, 2033. After the exercise, zero options from that grant remain. The Form 4 was signed by Meghan E. Jauhar as attorney-in-fact for Christine M. DeBiase.

What Was Disclosed

The filing reports two employee stock option exercises and corresponding open-market sales by DeBiase on November 6, 2026, covering a combined 28,652 shares of Allstate common stock, leaving her with 12,066.904 shares held directly and 3,642 derivative securities remaining.